Literature DB >> 7500273

Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.

K R Oldenburg1, K T Vo, G A Smith, H E Selick.   

Abstract

In recent years there has been an increased interest in the use of oligonucleotides as therapeutic agents. Oligonucleotide therapeutics may have significant potential over traditional drugs due to their high degree of specificity and increased affinity. The major drawbacks to the use of oligonucleotide therapeutics are the problems associated with their delivery and their relative instability in serum. The serum instability problem has been partially overcome through the use of oligonucleotides with modified backbones. Transdermal electrotransport may be used to overcome the problems associated with delivery. Here we report the use of transdermal electrotransport in the delivery of oligonucleotides across hairless mouse skin. The effects of pH, salt concentration, current density, and oligonucleotide concentration, structure, and length have been investigated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500273     DOI: 10.1002/jps.2600840803

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Visualization and analysis of electroosmotic flow in hairless mouse skin.

Authors:  B D Bath; H S White; E R Scott
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.

Authors:  W Lin; M Cormier; A Samiee; A Griffin; B Johnson; C L Teng; G E Hardee; P E Daddona
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

3.  Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation.

Authors:  V Regnier; V Préat
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

4.  Iontophoresis of bases, nucleosides, and nucleotides.

Authors:  R van der Geest; F Hueber; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

5.  Iontophoresis of poly-L-lysines: the role of molecular weight?

Authors:  N G Turner; L Ferry; M Price; C Cullander; R H Guy
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

6.  Iontophoretic delivery of a telomeric oligonucleotide.

Authors:  R M Brand; P L Iversen
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

Review 7.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.